These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
192 related articles for article (PubMed ID: 22174378)
1. Soluble guanylyl cyclase α1 and p53 cytoplasmic sequestration and down-regulation in prostate cancer. Cai C; Hsieh CL; Gao S; Kannan A; Bhansali M; Govardhan K; Dutta R; Shemshedini L Mol Endocrinol; 2012 Feb; 26(2):292-307. PubMed ID: 22174378 [TBL] [Abstract][Full Text] [Related]
2. COP9 subunits 4 and 5 target soluble guanylyl cyclase α1 and p53 in prostate cancer cells. Bhansali M; Shemshedini L Mol Endocrinol; 2014 Jun; 28(6):834-45. PubMed ID: 24725084 [TBL] [Abstract][Full Text] [Related]
3. Androgen regulation of soluble guanylyl cyclasealpha1 mediates prostate cancer cell proliferation. Cai C; Chen SY; Zheng Z; Omwancha J; Lin MF; Balk SP; Shemshedini L Oncogene; 2007 Mar; 26(11):1606-15. PubMed ID: 16964290 [TBL] [Abstract][Full Text] [Related]
4. Zinc Finger 280B regulates sGCα1 and p53 in prostate cancer cells. Gao S; Hsieh CL; Zhou J; Shemshedini L PLoS One; 2013; 8(11):e78766. PubMed ID: 24236047 [TBL] [Abstract][Full Text] [Related]
5. A peptide against soluble guanylyl cyclase α1: a new approach to treating prostate cancer. Gao S; Hsieh CL; Bhansali M; Kannan A; Shemshedini L PLoS One; 2013; 8(5):e64189. PubMed ID: 23724033 [TBL] [Abstract][Full Text] [Related]
6. Elevation of soluble guanylate cyclase suppresses proliferation and survival of human breast cancer cells. Wen HC; Chuu CP; Chen CY; Shiah SG; Kung HJ; King KL; Su LC; Chang SC; Chang CH PLoS One; 2015; 10(4):e0125518. PubMed ID: 25928539 [TBL] [Abstract][Full Text] [Related]
7. Peptide B targets soluble guanylyl cyclase α1 and kills prostate cancer cells. Zhou J; Gao S; Hsieh CL; Malla M; Shemshedini L PLoS One; 2017; 12(8):e0184088. PubMed ID: 28859127 [TBL] [Abstract][Full Text] [Related]
8. Soluble guanylate cyclase-alpha1 deficiency selectively inhibits the pulmonary vasodilator response to nitric oxide and increases the pulmonary vascular remodeling response to chronic hypoxia. Vermeersch P; Buys E; Pokreisz P; Marsboom G; Ichinose F; Sips P; Pellens M; Gillijns H; Swinnen M; Graveline A; Collen D; Dewerchin M; Brouckaert P; Bloch KD; Janssens S Circulation; 2007 Aug; 116(8):936-43. PubMed ID: 17679618 [TBL] [Abstract][Full Text] [Related]
9. Gender-specific hypertension and responsiveness to nitric oxide in sGCalpha1 knockout mice. Buys ES; Sips P; Vermeersch P; Raher MJ; Rogge E; Ichinose F; Dewerchin M; Bloch KD; Janssens S; Brouckaert P Cardiovasc Res; 2008 Jul; 79(1):179-86. PubMed ID: 18339647 [TBL] [Abstract][Full Text] [Related]
10. Notch activation augments nitric oxide/soluble guanylyl cyclase signaling in immortalized ovarian surface epithelial cells and ovarian cancer cells. El-Sehemy A; Chang AC; Azad AK; Gupta N; Xu Z; Steed H; Karsan A; Fu Y Cell Signal; 2013 Dec; 25(12):2780-7. PubMed ID: 24041655 [TBL] [Abstract][Full Text] [Related]
11. Role of the soluble guanylyl cyclase alpha1/alpha2 subunits in the relaxant effect of CO and CORM-2 in murine gastric fundus. De Backer O; Elinck E; Sips P; Buys E; Brouckaert P; Lefebvre RA Naunyn Schmiedebergs Arch Pharmacol; 2008 Nov; 378(5):493-502. PubMed ID: 18563392 [TBL] [Abstract][Full Text] [Related]
12. Challenging the Norm: The Unrecognized Impact of Soluble Guanylyl Cyclase Subunits in Cancer. Pino MTL; Rocca MV; Acosta LH; Cabilla JP Int J Mol Sci; 2024 Sep; 25(18):. PubMed ID: 39337539 [TBL] [Abstract][Full Text] [Related]
13. Effects of the JNK inhibitor anthra[1,9-cd]pyrazol-6(2H)-one (SP-600125) on soluble guanylyl cyclase alpha1 gene regulation and cGMP synthesis. Krumenacker JS; Kots A; Murad F Am J Physiol Cell Physiol; 2005 Oct; 289(4):C778-84. PubMed ID: 15888553 [TBL] [Abstract][Full Text] [Related]
14. Hypoxia induces downregulation of soluble guanylyl cyclase β1 by miR-34c-5p. Xu X; Wang S; Liu J; Dou D; Liu L; Chen Z; Ye L; Liu H; He Q; Raj JU; Gao Y J Cell Sci; 2012 Dec; 125(Pt 24):6117-26. PubMed ID: 23038777 [TBL] [Abstract][Full Text] [Related]
15. Regulation of p53 and suppression of apoptosis by the soluble guanylyl cyclase/cGMP pathway in human ovarian cancer cells. Fraser M; Chan SL; Chan SS; Fiscus RR; Tsang BK Oncogene; 2006 Apr; 25(15):2203-12. PubMed ID: 16288207 [TBL] [Abstract][Full Text] [Related]
16. Genetic modifiers of hypertension in soluble guanylate cyclase α1-deficient mice. Buys ES; Raher MJ; Kirby A; Shahid M; Baron DM; Hayton SR; Tainsh LT; Sips PY; Rauwerdink KM; Yan Q; Tainsh RE; Shakartzi HR; Stevens C; Decaluwé K; Rodrigues-Machado Mda G; Malhotra R; Van de Voorde J; Wang T; Brouckaert P; Daly MJ; Bloch KD J Clin Invest; 2012 Jun; 122(6):2316-25. PubMed ID: 22565307 [TBL] [Abstract][Full Text] [Related]
17. Interstitial cells of Cajal are innervated by nitrergic nerves and express nitric oxide-sensitive guanylate cyclase in the guinea-pig gastrointestinal tract. Iino S; Horiguchi K; Nojyo Y Neuroscience; 2008 Mar; 152(2):437-48. PubMed ID: 18280665 [TBL] [Abstract][Full Text] [Related]
18. Hydrogen peroxide alters splicing of soluble guanylyl cyclase and selectively modulates expression of splicing regulators in human cancer cells. Cote GJ; Zhu W; Thomas A; Martin E; Murad F; Sharina IG PLoS One; 2012; 7(7):e41099. PubMed ID: 22911749 [TBL] [Abstract][Full Text] [Related]
19. Expression of a hyperactive androgen receptor leads to androgen-independent growth of prostate cancer cells. Hsieh CL; Cai C; Giwa A; Bivins A; Chen SY; Sabry D; Govardhan K; Shemshedini L J Mol Endocrinol; 2008 Jul; 41(1):13-23. PubMed ID: 18469090 [TBL] [Abstract][Full Text] [Related]
20. The bradykinin/soluble guanylate cyclase signaling pathway is impaired in androgen-independent prostate cancer cells. Chen ZJ; Vetter M; Che D; Liu S; Tsai ML; Chang CH Cancer Lett; 2002 Mar; 177(2):181-7. PubMed ID: 11825665 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]